Supported by: Federal Ministry of Research, Technology and Space

Medicine of the future: novel drugs, personalised therapies and AI

 

Seminar fee

Participation in the seminars is free of charge for scientists, university staff, and students throughout Germany. Please register using your university email address.

The project is funded by the GO-Bio initial program of the BMFTR.

Please note that your registration is binding. You can cancel your registration up to one week before the course begins without giving a reason.

Target audience

This project is suitable for master's students, doctoral candidates, postdoctoral researchers, and all academic staff in the life and natural sciences, medicine, and related fields who want to further develop their applicable ideas or inventions, ideally to the point of commercialization.

Program

The program and invitation to the seminar can be found here as a PDF file.

Speakers

Prof. Dr. Kannt heads the Drug Discovery and Preclinical Research departments at the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP. After studying biochemistry and obtaining his doctorate, he worked for almost 20 years in research and development at Sanofi and its predecessor companies, most recently as head of research for the field of concomitant and secondary diseases of diabetes. He is qualified in experimental pharmacology and teaches at the universities of Frankfurt and Heidelberg as well as at the Goethe Business School.

Prof. Dr. Gilbert spent five years in senior positions in the field of medical technology and digital health before being appointed to Dresden in 2022 as the first European professor of medical device regulatory science in the field of AI and digital health. There he teaches and conducts research. His research focuses on the further development of regulatory science in digital medicine and AI-supported medical devices.

Location

The seminar will take place online via the BigBlueButton (BBB) web conferencing system. You can open BBB via a link in your web browser. All you need to do is click on the link to join the seminar. We will send you the link by email in good time. Access will be open from 12:50 p.m.

Event Information

Event Date 24.04.2026 | 13:00 Uhr
Event End Date 24.04.2026 | 15:05 Uhr
Cut Off Date 23.04.2026
Individual Price Free of charge
Programm
13:00 h

Begrüßung
Mandy Ascensi, TransMIT GmbH

13:15 h

New types of drugs
Prof. Dr. Aimo Kannt, Fraunhofer ITMP

14:00 h

New regulatory thinking is needed for AI-based personalized drug and cell therapies in precision oncology
Prof. Dr. Stephen Henry Gilbert, TU Dresden

15:00 h

Schlussbemerkungen

15:05 h

Ende der Veranstaltung

(Programmänderungen / Ergänzungen vorbehalten)

Das Programm und der Flyer für diese Veranstaltung sind hier als PDF-Datei zu finden.

Organizer

TransMIT Gesellschaft für Technologietransfer mbH

Ihre Ansprechpartnerin:
Dipl.-Biol. Mandy Ascensi
Projektleiterin GO-Bio initial
TransMIT Gesellschaft für Technologietransfer mbH
Kerkrader Straße 3
D-35394 Gießen
Tel. +49 641 94364 36
go-bio-initial@transmit.de

Location Online